George Kottayil - Nov 10, 2021 Form 3 Insider Report for Acasti Pharma Inc. (ACST)

Role
COO, US
Signature
/s/ Jason Comerford, Attorney-in-Fact
Stock symbol
ACST
Transactions as of
Nov 10, 2021
Transactions value $
$0
Form type
3
Date filed
11/23/2021, 04:00 PM
Next filing
Jun 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ACST Class A Common Shares 2.22M Nov 10, 2021 Direct
holding ACST Class A Common Shares 746K Nov 10, 2021 By Kottayil Grace Pharma LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACST Share Option (Right to Buy) Nov 10, 2021 Class A Common Shares 288K $1.63 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 287,900 Class A common shares underlying 287,900 share options granted on November 10, 2021. These share options vest on an even and quarterly basis over 36 months.
F2 Based on conversion of exercise price of C$2.05 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7959 on the date of grant.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney